Regular Paper
No Attenuation of Ischaemic Preconditioning by the Calcium Antagonist Nisoldipine

https://doi.org/10.1006/jmcc.1996.0169Get rights and content

Abstract

In anaesthetized dogs, intracoronary infusion of calcium prior to a prolonged ischaemic period reduced infarct size, thereby mimicking the protective effects ofischaemic preconditioningand suggesting that an increase in the intracellular calcium concentration might be an important mechanism underlying this phenomenon. The aim was to determine whether pretreatment with the calcium antagonist nisoldipine attenuates the reduction in infarct size achieved by ischaemic preconditioning. In 10 enflurane-anaesthetized pigs serving as controls (group 1), the inflow into the cannulated left anterior descending coronary artery was reduced (low-flow ischaemia) to achieve a 90% reduction in an anterior myocardial work index (sonomicrometry) for 90 min. In 11 pigs (group 2), a cylcle of 10 min of low-flow ischaemia and 15 min of reperfusion (preconditioning) preceded the prolonged ischaemia. In groups 3 (n=9) and 4 (n=7), nisoldipine was administered by intravenous infusion (500 ng/kg/min) starting 40 min prior to and then throughout a protocol identical to that of groups 1 and 2, respectively. Subendocardial blood flow was measured with radiolabelled microspheres. Infarct size (% area at risk) was determined by triphenyltetrazolium staining in all pigs after 120 min of reperfusion. Subendocardial blood flow in the area at risk was similar in all four groups (group 1: 0.09±0.04 ml/min/g; group 2: 0.05±0.03; group 3: 0.09±0.03; group 4: 0.07±0.03). Group 2 had reduced infarct size when compared with group 1 (2.6±3.0%v12.4±8.7%,P=0.004), and there was a trend for a reduction in infarct size following nisoldipine treatment (group 3: 10.2±7.1%, group 4: 1.6±2.8%,P=0.01). Thus administration of nisoldipine in pigs tended to decrease infarct size, and did not abolish the cardioprotection afforded by ischaemic preconditioning.

References (0)

Cited by (22)

  • The in-situ pig heart with regional ischemia/reperfusion - Ready for translation

    2011, Journal of Molecular and Cellular Cardiology
    Citation Excerpt :

    In the following, we will focus on myocardial infarction as endpoint because it is the most robust and irreversible endpoint, and all cardioprotective maneuvers are essentially defined through reduction of infarct size [40–42]. Apart from infarct size reduction by endogenous cardioprotective phenomena, the cardioprotective potential of drugs can be determined from the observed reduction in infarct size, along with potential favorable effects on systemic hemodynamics and collateral blood flow [43–48]. Myocardial infarction develops over time in close dependence on the residual collateral blood flow.

View all citing articles on Scopus

Please address all correspondence to: Professor Dr Gerd Heusch, Department of Pathophysiology, Universitätsklinikum Essen, Hufelandstrasse 55, 45122 Essen, Germany.

View full text